Long-term follow-up of patients with moderate aplastic anemia and pure red cell aplasia treated with daclizumab
Haematologica Sloand et al.
95: 382
Sloand et al. Supplementary Appendix
Sloand et al. Supplementary Appendix
Files in this Data Supplement: